Impact of the Microbiome on Immune Therapy in Kidney Cancer

At the Society of Urologic Oncology Annual Meeting, Sumanta K. Pal, MD, City of Hope, and Christopher Wallis, MD, PhD, FRCSC, University of Toronto, break down the role of the microbiome and response in patients with kidney cancer.

Together, they address ways to mediate the microbiome, the role of transplantation, and potential for immunotherapy in bladder cancer.